Choosing among Competing Blockbusters: Does the Identity of the Third-party Payer Matter for Prescribing Doctors?

Abstract

TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the third-party payer affects doctors choice between the three available… (More)

Topics

9 Figures and Tables

Cite this paper

@inproceedings{Dalen2009ChoosingAC, title={Choosing among Competing Blockbusters: Does the Identity of the Third-party Payer Matter for Prescribing Doctors?}, author={Dag Morten Dalen and Enrico Sorisio and Steinar Str\om and Ugo Colombino and Erik Hern{\ae}s and Marilena Locatelli and Kjell Arne Brekke and Karen Evelyn Hauge and Jo Thori Lind and Karine Nyborg and Benedicte Carlsen and Alessandro Corsi and Fredrik Willumsen and Steinar Holden and Fredrik Wulfsberg and Petter Vegard Hansen and Finn R. F\orsund}, year={2009} }